| Financial Year |
March 31 2023 |
| Monetary Funds |
275,223,872.74 |
| Held-for-trading Financial Assets |
50,786,059.40 |
| Notes Receivable |
-- |
| Accounts Receivable |
91,713,376.77 |
| Advances to Suppliers |
17,858,729.49 |
| Other Receivables |
6,674,107.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
198,971,071.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
10,000,000.00 |
| Other Current Assets |
5,624,837.72 |
| Total Current Assets |
662,626,342.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
474,580.17 |
| Long-term Equity Investment |
29,732,533.29 |
| Investment Properties |
-- |
| Fixed Assetes |
556,749,746.92 |
| Under-construction Projects |
182,121,737.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
98,090,969.87 |
| R&D expenses |
39,545,436.10 |
| Goodwill |
79,576,308.08 |
| Long-Term Deferred and Prepaid Expenses |
3,191,956.60 |
| Deferred Income Tax Assets |
5,456,135.84 |
| Other Non-Current Assets |
23,374,911.11 |
| Sub-Total of Non-Current Assets |
1,122,306,914.53 |
| Total Assets |
1,784,933,256.98 |
| Short-Term Loans |
148,635,304.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
138,886,810.46 |
| Accounts Payable |
103,996,608.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,282,087.97 |
| Taxes Payable |
14,079,971.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
28,217,576.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,514,140.66 |
| Sub-Total of Current Liabilities |
484,520,698.32 |
| Long-term Loans |
45,140,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
5,140,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,348,012.10 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
102,743,371.95 |
| Total Liabilities |
587,264,070.27 |
| Paid-In Capital(Or Share Stock) |
397,374,700.00 |
| Capital Surplus |
74,147,488.42 |
| Surplus Reserve |
83,018,849.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
569,215,410.38 |
| Minority Stockholder's Interest |
73,722,348.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,123,946,838.23 |
| Owner's Equity（Stockholder's Equity） |
1,197,669,186.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,784,933,256.98 |
